Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Treasury Shares (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Treasury Shares for 9 consecutive years, with $24000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Treasury Shares fell 95.1% to $24000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $24000.0, a 95.1% decrease, with the full-year FY2024 number at $24000.0, down 95.1% from a year prior.
  • Treasury Shares was $24000.0 for Q4 2024 at Usana Health Sciences, down from $490000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $490000.0 in Q4 2023 to a low of $11000.0 in Q1 2021.
  • A 4-year average of $184400.0 and a median of $24000.0 in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 3108.33% in 2022, then crashed 95.1% in 2024.
  • Usana Health Sciences' Treasury Shares stood at $11000.0 in 2021, then soared by 3400.0% to $385000.0 in 2022, then rose by 27.27% to $490000.0 in 2023, then plummeted by 95.1% to $24000.0 in 2024.
  • Per Business Quant, the three most recent readings for USNA's Treasury Shares are $24000.0 (Q4 2024), $490000.0 (Q4 2023), and $385000.0 (Q4 2022).